Dermal Fillers
YVOIRE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11241
Yvoire Y-Solution 720
In stock
Volume
1. x 1 mL
Laboratory
LG Chem
Origin
South Korea
Indication
Anti-ageing correction with projection and flexibility
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Yvoire Y-Solution 720 is a cross-linked hyaluronic acid dermal filler at 20 mg/mL (2.0%) with 0.3% lidocaine, manufactured in South Korea as part of the YVOIRE Y-Solution line. The manufacturer describes the range as built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that support projection, flexibility and resistance to the movement of facial expressions. The Y-Solution numbers are lift tiers rather than concentrations: the 720 is the strongest lift tier in the line, indicated for severe and extreme volume loss and for correction of facial morphological asymmetry, while stating the same 20 mg/mL composition as the 540. Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks. Supplied as a single 1 mL syringe with two Terumo thin-wall 27G needles enclosed, CE-marked under Notified Body 2292, and intended for professional use by qualified practitioners only. Shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references.
Key Benefits of Yvoire Y-Solution 720
- Combines high elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides projection with flexibility, designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 20 mg/mL with 0.3% lidocaine
- Built on the manufacturer's S-HICE cross-linking process
- The strongest lift tier in the Y-Solution line, indicated by the manufacturer for severe and extreme volume loss and for facial morphological asymmetry
- Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks
- Supplied with two Terumo thin-wall 27G needles
- CE-marked medical device under Notified Body 2292
Indications and Professional Use
Main indications
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring elasticity, cohesion and resistance to facial movement
Professional use
Yvoire Y-Solution 720 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 27G needles, a heavier gauge than the 29G supplied with Y-Solution 360, consistent with a more concentrated gel at 20 mg/mL. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking anti-ageing correction with projection that holds through facial movement, as assessed by a qualified practitioner. The manufacturer's leaflet gives severe and extreme volume loss and correction of facial morphological asymmetry among its indications, making it the strongest lift tier in the Y-Solution line; patients wanting the lightest option are better served by the 360 reference. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
How Yvoire Y-Solution 720 Works
The Yvoire 720 filler works through cross-linked hyaluronic acid at 20 mg/mL (2.0%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between high elasticity and cohesion. The intended behaviour is spring-like: the gel holds projection while still flexing with the face, which is what the Y-Solution line is positioned around rather than static filling. It is the strongest lift tier in the line, against the lightest 12 mg/mL of Y-Solution 360, and the two Terumo thin-wall 27G needles enclosed reflect the heavier body. Note that the 540 states the same 20 mg/mL composition, so the difference between those two is lift positioning rather than concentration. The 0.3% lidocaine acts locally to improve comfort during injection.
Why Order From Allpara
Allpara offers genuine, verified YVOIRE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Yvoire Y-Solution 720 differ from the 360 and the 540?
The 360 is the lightest at 12 mg/mL with finer 29G needles. The 720 and the 540 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, so they differ in lift positioning rather than in stated composition. The Y-Solution numbers are lift tiers, not concentrations.
How long do the results of Yvoire Y-Solution 720 last?
The manufacturer publishes no duration of effect. Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks, which is the only figure with a published source behind it.
More from LG Chem
Clinic alternatives
Mesotherapy
Skin Boosters
/ Recently viewed
Pick up where you left off
Yvoire Y-Solution 720
In stock
CE Marked
Yvoire Y-Solution 720 is a cross-linked hyaluronic acid dermal filler at 20 mg/mL (2.0%) with 0.3% lidocaine, manufactured in South Korea as part of the YVOIRE Y-Solution line. The manufacturer describes the range as built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that support projection, flexibility and resistance to the movement of facial expressions. The Y-Solution numbers are lift tiers rather than concentrations: the 720 is the strongest lift tier in the line, indicated for severe and extreme volume loss and for correction of facial morphological asymmetry, while stating the same 20 mg/mL composition as the 540. Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks. Supplied as a single 1 mL syringe with two Terumo thin-wall 27G needles enclosed, CE-marked under Notified Body 2292, and intended for professional use by qualified practitioners only. Shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references.
Key Benefits of Yvoire Y-Solution 720
- Combines high elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides projection with flexibility, designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 20 mg/mL with 0.3% lidocaine
- Built on the manufacturer's S-HICE cross-linking process
- The strongest lift tier in the Y-Solution line, indicated by the manufacturer for severe and extreme volume loss and for facial morphological asymmetry
- Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks
- Supplied with two Terumo thin-wall 27G needles
- CE-marked medical device under Notified Body 2292
Indications and Professional Use
Main indications
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring elasticity, cohesion and resistance to facial movement
Professional use
Yvoire Y-Solution 720 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 27G needles, a heavier gauge than the 29G supplied with Y-Solution 360, consistent with a more concentrated gel at 20 mg/mL. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking anti-ageing correction with projection that holds through facial movement, as assessed by a qualified practitioner. The manufacturer's leaflet gives severe and extreme volume loss and correction of facial morphological asymmetry among its indications, making it the strongest lift tier in the Y-Solution line; patients wanting the lightest option are better served by the 360 reference. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
How Yvoire Y-Solution 720 Works
The Yvoire 720 filler works through cross-linked hyaluronic acid at 20 mg/mL (2.0%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between high elasticity and cohesion. The intended behaviour is spring-like: the gel holds projection while still flexing with the face, which is what the Y-Solution line is positioned around rather than static filling. It is the strongest lift tier in the line, against the lightest 12 mg/mL of Y-Solution 360, and the two Terumo thin-wall 27G needles enclosed reflect the heavier body. Note that the 540 states the same 20 mg/mL composition, so the difference between those two is lift positioning rather than concentration. The 0.3% lidocaine acts locally to improve comfort during injection.
Why Order From Allpara
Allpara offers genuine, verified YVOIRE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Yvoire Y-Solution 720 differ from the 360 and the 540?
The 360 is the lightest at 12 mg/mL with finer 29G needles. The 720 and the 540 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, so they differ in lift positioning rather than in stated composition. The Y-Solution numbers are lift tiers, not concentrations.
How long do the results of Yvoire Y-Solution 720 last?
The manufacturer publishes no duration of effect. Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks, which is the only figure with a published source behind it.
More from LG Chem
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.